# Cannformatics

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/cannformatics
- **Dataset:** https://optimly.ai/brand/cannformatics.json
- **Markdown:** https://optimly.ai/brand/cannformatics/llms.txt
- **Official website:** https://cannformatics.com
- **Slug:** cannformatics
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** Proprietary C-Res™ biomarker technology that measures metabolic biomarkers from saliva samples to quantify individual patient responses to medical cannabis, coupled with an AI-powered bioinformatics platform to optimize products, dosage, and consumption methods for personalized treatment.
Source: Brand's website (https://cannformatics.com) · 2026-10-04

- **Description:** Cannformatics delivers predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life. The company uses proprietary Cannabis-Responsive™ (C-Res™) biomarker technology and an AI-powered cannabinoid-based pharmacometabolomics approach to personalize medical cannabis treatment, focusing initially on neurological and neuropsychiatric disorders like autism and dementia.
Source: Brand's website (https://cannformatics.com) · 2026-10-04

## Offerings

- **Core capabilities:** Cannabis-Responsive™ (C-Res™) biomarker technology; AI-powered bioinformatics platform for personalized treatment guidance.
Source: Brand's website (https://cannformatics.com) · 2026-10-04

- **Pricing:** Not disclosed.
Source: Brand's website (https://cannformatics.com) · 2026-10-04

## Audience

- **Target industry:** Patients with neurological and neuropsychiatric disorders (e.g., autism spectrum disorder, dementia); Healthcare Providers (HCPs) recommending medical cannabis.
Source: Brand's website (https://cannformatics.com) · 2026-10-04

Page last updated 2026-10-17.